Affinity Biopharmaceutical Co., Ltd.

We are a clinical stage biopharma on Tumor MicroEnvironment Activated (TMEA) multispecific therapeutics. Our exclusive chemical conjugate linker and TMEA platform could be broadly applied to small molecules, cytokines, antibodies, fusion proteins, and ADC

Address

Visit website (opens in a new tab)
Loading